Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 327,738 shares, a decline of 64.1% from the August 15th total of 913,482 shares. Approximately 0.5% of the shares of the company are sold short. Based on an average daily volume of 718,829 shares, the days-to-cover ratio is currently 0.5 days.

Institutional Trading of Bioceres Crop Solutions

Several large investors have recently made changes to their positions in BIOX. Invesco Ltd. acquired a new position in shares of Bioceres Crop Solutions during the fourth quarter worth $45,000. Ardsley Advisory Partners LP raised its position in Bioceres Crop Solutions by 691.7% during the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after purchasing an additional 415,000 shares during the last quarter. GAM Holding AG acquired a new position in Bioceres Crop Solutions during the 4th quarter worth about $655,000. State of Wisconsin Investment Board bought a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at about $247,000. Finally, Marshall Wace LLP grew its position in shares of Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after buying an additional 382,744 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX traded down $0.00 on Friday, reaching $0.42. 63,480 shares of the company’s stock were exchanged, compared to its average volume of 470,305. The company has a fifty day moving average of $0.38 and a 200-day moving average of $0.44. Bioceres Crop Solutions has a twelve month low of $0.30 and a twelve month high of $2.19. The company has a market capitalization of $26.50 million, a price-to-earnings ratio of -0.11 and a beta of 0.44. The company has a current ratio of 0.88, a quick ratio of 0.70 and a debt-to-equity ratio of 0.57.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, July 13th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $2.00.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.